Cross-Sectional Comparison of Subclinical Outcomes Between the MHO and MUO Phenotypes
| Outcomes . | Events/n in MHO Group . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)a . |
|---|---|---|---|
| Subclinical CVD score: examination 6 (1995–1998) | |||
| Obesity subphenotypes at examination 6 | |||
| MHO vs MUO | 42/149 | 0.47 (0.31–0.72) | 0.57 (0.36–0.89) |
| CAC: examination 7 (1998–2001) | |||
| Obesity subphenotypes at examination 7 | |||
| MHO vs MUO | 41/95 | 0.41 (0.25–0.68) | 0.51 (0.29–0.88) |
| Outcomes . | Events/n in MHO Group . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)a . |
|---|---|---|---|
| Subclinical CVD score: examination 6 (1995–1998) | |||
| Obesity subphenotypes at examination 6 | |||
| MHO vs MUO | 42/149 | 0.47 (0.31–0.72) | 0.57 (0.36–0.89) |
| CAC: examination 7 (1998–2001) | |||
| Obesity subphenotypes at examination 7 | |||
| MHO vs MUO | 41/95 | 0.41 (0.25–0.68) | 0.51 (0.29–0.88) |
ORs are from the models in Table 5 relating all obesity phenotypes to subclinical outcomes but with MUO as the reference group; only the MHO vs MUO comparisons are shown.
Adjusted for age, sex, and current smoking.
Cross-Sectional Comparison of Subclinical Outcomes Between the MHO and MUO Phenotypes
| Outcomes . | Events/n in MHO Group . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)a . |
|---|---|---|---|
| Subclinical CVD score: examination 6 (1995–1998) | |||
| Obesity subphenotypes at examination 6 | |||
| MHO vs MUO | 42/149 | 0.47 (0.31–0.72) | 0.57 (0.36–0.89) |
| CAC: examination 7 (1998–2001) | |||
| Obesity subphenotypes at examination 7 | |||
| MHO vs MUO | 41/95 | 0.41 (0.25–0.68) | 0.51 (0.29–0.88) |
| Outcomes . | Events/n in MHO Group . | Unadjusted OR (95% CI) . | Adjusted OR (95% CI)a . |
|---|---|---|---|
| Subclinical CVD score: examination 6 (1995–1998) | |||
| Obesity subphenotypes at examination 6 | |||
| MHO vs MUO | 42/149 | 0.47 (0.31–0.72) | 0.57 (0.36–0.89) |
| CAC: examination 7 (1998–2001) | |||
| Obesity subphenotypes at examination 7 | |||
| MHO vs MUO | 41/95 | 0.41 (0.25–0.68) | 0.51 (0.29–0.88) |
ORs are from the models in Table 5 relating all obesity phenotypes to subclinical outcomes but with MUO as the reference group; only the MHO vs MUO comparisons are shown.
Adjusted for age, sex, and current smoking.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
